CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-03 | SMITH IAN F Director | Option exercise | +15,570 | 68,809 | ||
| 2023-07-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −15,570 | 31,139 | ||
| 2023-06-06 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | Stone Adam Leo Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | Koppel Adam Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | Keresty Georgia Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | Kahn Clare Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | Sullivan Lynne Marie Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | Nagendran Sukumar Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | Ganot Ilan Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | SMITH IAN F Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-06 | Freed Martin I Director | Grant or award · Director Stock Option (Right to Buy) | +9,650 | 9,650 | ||
| 2023-06-02 | Ganot Ilan Director | Option exercise | +1,583 | 87,758 | ||
| 2023-06-02 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −1,583 | 3,166 | ||
| 2023-05-02 | Ganot Ilan Director | Option exercise | +1,553 | 4,640 | ||
| 2023-05-02 | Ganot Ilan Director | Sale | −487 | $4.85 | $2K | 4,153 |
| 2023-05-02 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −1,553 | 1,553 | ||
| 2023-04-03 | SMITH IAN F Director | Option exercise | +15,569 | 53,239 | ||
| 2023-04-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −15,569 | 46,709 |
Page 16 of 21 · 403 trades